Skip to content
    PFM Health Sciences logo

    PFM Health Sciences

    San Francisco, California, United StatesFounded 2004
    www.pfmhealthsciences.comLinkedIn
    HealthcareBiotech & Life Sciences

    PFM Health Sciences (formerly Partner Fund Management) is a San Francisco-based healthcare investment advisor founded in 2004. The firm invests across the capital structure in both public and private healthcare companies, spanning biopharma, medical technology, life sciences, and healthcare services.

    56% of their portfolio is in Healthcare. Their most common stage is series-c (40% of deals). Average disclosed round size is $149.8M (across 24 rounds with reported amounts).

    Find people at PFM Health Sciences on Goldilocks AI

    Portfolio

    20

    Fund Size

    —

    Top Stage

    Series C

    Last 12 Mo

    0

    Team

    BG

    Brian Grossman

    Managing Partner, CIO and Portfolio Manager

    CM

    Christopher Mosellen

    Head of Trading

    DM

    Darren Mooney

    General Counsel & Chief Compliance Officer

    GL

    Graham Low

    Head of Business Development

    JA

    Jonathan Aljoe

    Chief Financial Officer

    DL

    Darwin Li

    LH

    Lee Hathaway

    RB

    Raghav Bhargava

    VK

    Vivek Khanna

    Portfolio Breakdown

    Stage Distribution

    Sector Distribution

    Investment Activity

    DealsAvg Round Size

    Portfolio

    25 investments
    CompanyRoundAmountDate
    Mendaera logoMendaeraSeries B$73MSep 2026
    Mendaera logoMendaeraSeries B$73MJan 2026
    CareSyntax logoCareSyntaxSeries C$180MAug 2024
    Mendaera logoMendaeraSeries B$73MJan 2024
    COMPASS Pathways logoCOMPASS PathwaysSeries A$285MAug 2023
    Metagenomi logoMetagenomiSeries B$175MJan 2022
    Lark Health logoLark HealthSeries D$100MOct 2021
    LLark TechnologiesSeries D$100MOct 2021
    Lark logoLarkSeries D$100MOct 2021
    Cytrellis Biosystems logoCytrellis BiosystemsSeries C$50MSep 2021
    CCytrellisSeries C$50MSep 2021
    Turnstone Biologics logoTurnstone BiologicsSeries D$80MJul 2021
    CMR Surgical logoCMR SurgicalSeries D$600MJun 2021
    CCollectivehealth IncSeries F$280MMay 2021
    Crossover Health logoCrossover HealthSeries D$168MMar 2021
    Crossover Health logoCrossover HealthSeries D$168MMar 2021
    Io Biotech logoIo BiotechSeries B—Jan 2021
    PPersonal Genome Diagnostics (PGDx)Series C$103MJan 2021
    CareSyntax logoCareSyntaxSeries C$100MJan 2021
    Outset Medical logoOutset MedicalSeries E$125MFeb 2020
    Theranos logoTheranosSeries C$96.1MJan 2014
    PGDx logoPGDxSeries C$103MJan 2014
    Theranos logoTheranosSeries C$198MJan 2004
    Caribou logoCaribouSeries C$115M—
    NNikang Therapeutics, Inc.Series C$200M—

    Top Co-Investors

    Deerfield5 shared
    Perceptive Advisors4 shared
    Sands Capital4 shared
    Founders Fund4 shared
    D1 Capital Partners3 shared
    RA Capital Management3 shared
    Surveyor Capital3 shared
    Avidity Partners3 shared
    OrbiMed3 shared
    Threshold Ventures3 shared
    Lux Capital3 shared
    Franklin Templeton3 shared
    Olive Tree Ventures3 shared
    King River Capital3 shared
    Tim Draper2 shared
    ARCH Venture Partners2 shared
    Samsara BioCapital2 shared
    Soleus Capital2 shared
    Vivo Capital2 shared
    HBM Healthcare Investments2 shared

    Last updated: 27 September 2026